Both GLP-1 receptor agonists and TZDs may cause insomnia, and GLP-1 receptor agonists may cause rash at the injection site and constipation; drug-specific adverse reactions associated with TZDs include mastopathy, muscle cramping, and peripheral edema. This evidence concerns the gene GLP1R and insomnia measurement.